Arbeitspapier

The impact of higher standards in patent protection for pharmaceutical industries under the TRIPS Agreement: A comparative study of China and India

A comparative study is undertaken that explores Chinese and Indian pharmaceutical industries under different patent regimes. It is found that relative to India, which had implemented process patent until 2005, China with a product patent regime since 1993 suffers from both lower drug accessibility and availability (the latter is a missing parameter in the literature). Also, China lags behind in both lower R&D investment and patents filed by Chinese nationals. Based on these findings and associated legal interpretation, we conclude that higher patent protection in China generates negative impacts on the pharmaceutical industries. Thus, governments should utilize TRIPS flexibilities and other regimes like price control to offset the anticompetitive effect in designing patent policies.

ISBN
978-92-9230-082-1
Sprache
Englisch

Erschienen in
Series: WIDER Research Paper ; No. 2008/36

Klassifikation
Wirtschaft
Intellectual Property and Intellectual Capital
Chemicals; Rubber; Drugs; Biotechnology; Plastics
Empirical Studies of Trade
Thema
product patent
process patent
TRIPS
pharmaceutical industries
China
India
TRIPS
Patentrecht
Wohlfahrtseffekt
Pharmazeutische Industrie
China
Indien

Ereignis
Geistige Schöpfung
(wer)
Li, Xuan
Ereignis
Veröffentlichung
(wer)
The United Nations University World Institute for Development Economics Research (UNU-WIDER)
(wo)
Helsinki
(wann)
2008

Handle
Letzte Aktualisierung
10.03.2025, 11:43 MEZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Objekttyp

  • Arbeitspapier

Beteiligte

  • Li, Xuan
  • The United Nations University World Institute for Development Economics Research (UNU-WIDER)

Entstanden

  • 2008

Ähnliche Objekte (12)